Read the Beforeitsnews.com story here. Advertise at Before It's News here.
Profile image
By Notable Calls (Reporter)
Contributor profile | More stories
Story Views
Now:
Last hour:
Last 24 hours:
Total:

Tesla Motors (NASDAQ:TSLA): Investor meeting yielded significant positives, according to Goldman

% of readers think this story is Fact. Add your two cents.


Goldman Sachs has some interesting comments on Tesla Motors (NASDAQ:TSLA) after hosting an investor meetings with the company management in New York on April 20 and 21.

The takeaways:

Orders have picked up for the Model S, tracking at over 4,000 from around 3,400 at year’s end. The company expects to have 2012 production sold out soon and believes the first 12 months of production could be sold out by the end of this year. The company is on track to launch the Model S by mid-2012, having now sourced virtually all of its components, providing better cost visibility versus a few months ago. This has also provided added confidence around the 25% gross margin target for the program. With Tesla working successfully though many key design risks, Goldman now sees increased focus on managing vendor risk and large scale production. While the Model S production target remains at 20,000 for 2012, Tesla is configuring the Fremont facility to manufacture 20,000 units on one shift per year, as opposed to the 10,000 originally planed, in order to maximize upward production flexibility. The company has completed the build-out of numerous drivable “alpha” prototypes and expects to produce preproduction “beta” prototypes in the fall which will be shown to the public.

While the company believes it has enough liquidity to complete the Model S program on its own it expects to conduct a $100-$200 mn capital raise in the fall to help cover the upcoming Model X program which has been accelerated as well as a stepped-up investment in vertical integration and additional equipment from the former NUMMI plant which should be able to service Tesla’s production needs for more than five years.

Implications
Management’s reiteration of production and cost targets on the Model S post supplier sourcing and extensive prototype testing is a significant positive and gives the firm increased confidence that investors will be able to exceed the 25% annual returns used to discount their price target.

Notablecalls: While Goldman is not exactly a Tesla bull (Neutral rated, $29 tgt), the note does include some new information that may cause quite a stir among investors:

- Tesla seems to be readying for greater-than-forecast demand for Model S.

- The company has enough cash to complete the Model S program without additional financing. The offering, speculated to be a very n-t event may actually be 6 months away.

- Overall, everything seems to be going as planned. This is a surprise in itself as Tesla is a relatively new company and therefore prone to experience delays of all sorts.

Goldman is calling the info they gleaned from the management a significant positive. That’s a strong statement on a high-beta name like TSLA.

Not exactly a trading call but I thought to highlight the comments following the hugely positive note from Morgan Stanley back in March.

Read more at Notable Calls



Before It’s News® is a community of individuals who report on what’s going on around them, from all around the world.

Anyone can join.
Anyone can contribute.
Anyone can become informed about their world.

"United We Stand" Click Here To Create Your Personal Citizen Journalist Account Today, Be Sure To Invite Your Friends.

Lion’s Mane Mushroom

Mushrooms are having a moment. One fabulous fungus in particular, lion’s mane, may help improve memory, depression and anxiety symptoms. They are also an excellent source of nutrients that show promise as a therapy for dementia, and other neurodegenerative diseases. If you’re living with anxiety or depression, you may be curious about all the therapy options out there — including the natural ones.Our Lion’s Mane WHOLE MIND Nootropic Blend has been formulated to utilize the potency of Lion’s mane but also include the benefits of four other Highly Beneficial Mushrooms. Synergistically, they work together to Build your health through improving cognitive function and immunity regardless of your age. Our Nootropic not only improves your Cognitive Function and Activates your Immune System, But it benefits growth of Essential Gut Flora, further enhancing your Vitality.



Our Formula includes:

Lion’s Mane Mushrooms which Increase Brain Power through nerve growth, lessen anxiety, reduce depression, and improve concentration. Its an excellent adaptogen, promotes sleep and improves immunity.

Shiitake Mushrooms which Fight cancer cells and infectious disease, boost the immune system, promotes brain function, and serves as a source of B vitamins.

Maitake Mushrooms which regulate blood sugar levels of diabetics, reduce hypertension and boosts the immune system.

Reishi Mushrooms which Fight inflammation, liver disease, fatigue, tumor growth and cancer. They Improve skin disorders and soothes digestive problems, stomach ulcers and leaky gut syndrome.

Chaga Mushrooms which have anti-aging effects, boost immune function, improve stamina and athletic performance, even act as a natural aphrodisiac, fighting diabetes and improving liver function.

Try Our Lion’s Mane WHOLE MIND Nootropic Blend 60 Capsules. Today Be 100% Satisfied Or Receive A Full Money Back Guarantee Order Yours Today By Following This Link.

Report abuse

    Comments

    Your Comments
    Question   Razz  Sad   Evil  Exclaim  Smile  Redface  Biggrin  Surprised  Eek   Confused   Cool  LOL   Mad   Twisted  Rolleyes   Wink  Idea  Arrow  Neutral  Cry   Mr. Green

    MOST RECENT
    Load more ...

    SignUp

    Login

    Newsletter

    Email this story
    Email this story

    If you really want to ban this commenter, please write down the reason:

    If you really want to disable all recommended stories, click on OK button. After that, you will be redirect to your options page.